GLP-1 TV · Patient story · views checked Oct 2026
Bijan Salehizadeh - Retatrutide, Peptides, Hims vs Ro, and Lilly's War on Compounded GLP-1s
Our summary
A patient reviews the program. It has no captions we could read, so this is drawn from its title and description.
One person's experience, in their words. Not medical advice.
Key moments
From the creator's own chapters. Tap one to play from there.
- 0:00 Sponsor: Superpower
- 1:16 No one knows anything about Heidi Overton (FDA nominee)
- 6:29 Eli Lilly's war on 503A pharmacies
- 8:47 The Lilly "grand bargain"
- 13:49 When compounding becomes a "new drug"
- 17:34 Branded drugs crush margins
- 21:51 Hims management scorecard
- 26:29 Retatrutide reclassification fight
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- retatrutide
- Who is speaking
- Patient
Find more like it
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















